The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
1 - 25 of 20
| Title | Creator | Relation Is Part Of | ||
|---|---|---|---|---|
| 1 |
 |
Bilateral Visual Improvement with Unilateral Gene Therapy for Leber Hereditary Optic Neuropathy (LHON) (Video) | Nancy J. Newman; Mark Moster; Alfredo Sadun; Thomas Klopstock; Catherine Vignal-Clermont; Valerio Carelli; Patrick Yu Wai Man; Robert Sergott; Valerie Biousse; Laure Blouin; Magali Taiel; Pierre Burguiere; Caroline Chevalier; Katz Barrett; Jose-Alain Sahel | NANOS Annual Meeting 2020: Scientific Platform Session III |
| 2 |
 |
Gene Mediated Therapy for LHON | John Guy, MD | NANOS 2007: Novel Approaches to Treatment of Neuro-Ophthalmic Diseases: Part II: Neuroprotection and Other Methods for Salvaging Visual Function |
| 3 |
 |
Gene Therapy - Evolution and Therapeutic Applications (PDF) | Patrick Yu-Wai-Man | NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends |
| 4 |
 |
Gene Therapy - Evolution and Therapeutic Applications (Slides) | Patrick Yu-Wai-Man | NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology - 2020 Trends |
| 5 |
 |
Gene Therapy - Evolution and Therapeutic Applications (Video) | Patrick Yu-Wai-Man | NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends |
| 6 |
 |
Gene Therapy for Leber Congenital Amaurosis | William Hauswirth; Jijing Pang; Sanford Boye | NANOS 2007: Novel Approaches to Treatment of Neuro-Ophthalmic Diseases: Part II: Neuroprotection and Other Methods for Salvaging Visual Function |
| 7 |
 |
Gene Therapy to Abolish Congenital Nystagmus in RPE65-Deficient Canines | L. F. Dell'Osso, PhD; J. B. Jacobs, PhD; R. W. Hertle, MD; J. Bennett, MD, PhD; G. Acland, DVM | NANOS 2003: Scientific Platforms Presentations II |
| 8 |
 |
Genetic Manipulation for Inherited Neuodegenerative Diseases - Myth or Reality? (slideshow) | Patrick Yu-Wai-Man | NANOS Annual Meeting 2016: Hot Topics - Today and Tomorrow |
| 9 |
 |
Genetic Manipulation for Inherited Neurodegenerative Diseases - Myth or Reality? (.pdf) | Patrick Yu-Wai-Man | NANOS Annual Meeting 2016: Hot Topics - Today and Tomorrow |
| 10 |
 |
Genetic Manipulation for Inherited Neurodegenerative Diseases - Myth or Reality? (video) | Patrick Yu-Wai-Man | NANOS Annual Meeting 2016: Hot Topics - Today and Tomorrow |
| 11 |
 |
Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Serial Pretreatment Evaluation from Baseline to Two Years | Byron Lam; John Guy; Fawzi Abukhalil; Feuer William; Potyra Aroucha; Alexis Morante | NANOS 2012: Platform Presentation |
| 12 |
 |
Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters in Preparatory Phase Based on Onset of Visual Loss | Byron L. Lam; John R. Guy; William J. Feuer; Vittorio Porciatti; Ruth Vandenbroucke; Joyce C. Schiffman | NANOS 2013: Platform Presentations (Session II) |
| 13 |
 |
Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters in Preparatory Phase Based on Onset of Visual Loss | Byron L. Lam; John R. Guy; William J. Feuer; Vittorio Porciatti; Ruth Vandenbroucke; Joyce C. Schiffman | NANOS 2013: Platform Presentations (Session II) |
| 14 |
 |
Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial for G11778A Mutation | Byron Lam; John Guy; Vittorio Porciatti; Abukhalil Fawzi; Morante Alexis; Feuer William | NANOS 2010: Poster Presentations |
| 15 |
 |
Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial for G11778A Mutation | Byron Lam; John Guy; Vittorio Porciatti; Abukhalil Fawzi; Morante Alexis; Feuer William | NANOS 2010: Poster Presentations |
| 16 |
 |
Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial for G11778A Mutation: Serial Pretreatment Evaluation from Baseline to One Year | Byron Lam; John Guy; Fawzi Abukhalil; Vittorio Porciatti; William Feuer; Alexis Morante | NANOS 2011: Poster Presentations |
| 17 |
 |
Leber Hereditary Optic Neuropathy: from Bedside to Bench to Bedside | Nancy J. Newman | NANOS 2019: Jacobson Lecture |
| 18 |
 |
Safety/Acuity Outcomes 96-Weeks Post-Treatment with rAAV2/2-ND4; Gene Therapy for ND4 LHON: a Phase I/II Trial | Barrett Katz; Catherine Vignal; Celine Bouquet; Nitza Thomasson; Ann Galy; Serge Fitoussi; Jose Sahel | NANOS Annual Meeting 2018: Scientific Platform, Session I |
| 19 |
 |
Safety/Acuity Outcomes 96-Weeks Post-Treatment with rAAV2/2-ND4; Gene Therapy for ND4 LHON: a Phase I/II Trial | Barrett Katz; Catherine Vignal; Celine Bouquet; Nitza Thomasson; Ann Galy; Serge Fitoussi; Jose Sahel | NANOS Annual Meeting 2018: Scientific Platform, Session I |
| 20 |
 |
Stem Cells, Gene Therapy and the Neuro-Ophthalmologist | Jeffrey Bennett, MD, PhD | NANOS 2011: Hot Topics (Controversies) |
1 - 25 of 20